Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001815776-25-000047
Filing Date
2025-06-11
Accepted
2025-06-11 17:46:36
Documents
4
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749678389.html 4  
1 FORM 4 wk-form4_1749678389.xml 4 4003
2 EX-24 drapkinpoa.htm EX-24 5001
3 drapkinpoa001.jpg GRAPHIC 277141
4 drapkinpoa002.jpg GRAPHIC 49074
  Complete submission text file 0001815776-25-000047.txt   460105
Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Drapkin Kimberlee C (Reporting) CIK: 0001340881 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 251041068

Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Issuer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)